Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
- PMID: 20027217
- PMCID: PMC2791206
- DOI: 10.1371/journal.pntd.0000573
Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
Abstract
Background: Trachoma has been endemic in The Gambia for decades. National trachoma control activities have been in place since the mid-1980's, but with no mass antibiotic treatment campaign. We aimed to assess the prevalence of active trachoma and of actual ocular Chlamydia trachomatis infection as measured by polymerase chain reaction (PCR) in the two Gambian regions that had had the highest prevalence of trachoma in the last national survey in 1996 prior to planned national mass antibiotic treatment distribution in 2006.
Methodology/principal findings: Two stage random sampling survey in 61 randomly selected Enumeration Areas (EAs) in North Bank Region (NBR) and Lower River Region (LRR). Fifty randomly selected children aged under 10 years were examined per EA for clinical signs of trachoma. In LRR, swabs were taken to test for ocular C. trachomatis infection. Unadjusted prevalences of active trachoma were calculated, as would be done in a trachoma control programme. The prevalence of trachomatous inflammation, follicular (TF) in the 2777 children aged 1-9 years was 12.3% (95% CI 8.8%-17.0%) in LRR and 10.0% (95% CI 7.7%-13.0%) in NBR, with significant variation within divisions (p<0.01), and a design effect of 3.474. Infection with C. trachomatis was found in only 0.3% (3/940) of children in LRR.
Conclusions/significance: This study shows a large discrepancy between the prevalence of trachoma clinical signs and ocular C. trachomatis infection in two Gambian regions. Assessment of trachoma based on clinical signs alone may lead to unnecessary treatment, since the prevalence of active trachoma remains high but C. trachomatis infection has all but disappeared. Assuming that repeated infection is required for progression to blinding sequelae, blinding trachoma is on course for elimination by 2020 in The Gambia.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial.PLoS Negl Trop Dis. 2010 Nov 2;4(11):e861. doi: 10.1371/journal.pntd.0000861. PLoS Negl Trop Dis. 2010. PMID: 21072224 Free PMC article. Clinical Trial.
-
Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities.PLoS Negl Trop Dis. 2010 Oct 5;4(10):e835. doi: 10.1371/journal.pntd.0000835. PLoS Negl Trop Dis. 2010. PMID: 20957147 Free PMC article.
-
Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal.PLoS Negl Trop Dis. 2011 Aug;5(8):e1234. doi: 10.1371/journal.pntd.0001234. Epub 2011 Aug 2. PLoS Negl Trop Dis. 2011. PMID: 21829735 Free PMC article.
-
The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment.PLoS Negl Trop Dis. 2016 Oct 26;10(10):e0005080. doi: 10.1371/journal.pntd.0005080. eCollection 2016 Oct. PLoS Negl Trop Dis. 2016. PMID: 27783678 Free PMC article. Review.
-
Stopping azithromycin mass drug administration for trachoma: A systematic review.PLoS Negl Trop Dis. 2021 Jul 8;15(7):e0009491. doi: 10.1371/journal.pntd.0009491. eCollection 2021 Jul. PLoS Negl Trop Dis. 2021. PMID: 34237074 Free PMC article.
Cited by
-
Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis.Front Microbiol. 2011 Feb 10;2:10. doi: 10.3389/fmicb.2011.00010. eCollection 2011. Front Microbiol. 2011. PMID: 21747780 Free PMC article.
-
Current Research of Chlamydial Infection Diseases in China.Chin Med J (Engl). 2018 Feb 20;131(4):486-489. doi: 10.4103/0366-6999.225063. Chin Med J (Engl). 2018. PMID: 29451157 Free PMC article. No abstract available.
-
Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.PLoS Negl Trop Dis. 2017 Jan 18;11(1):e0005230. doi: 10.1371/journal.pntd.0005230. eCollection 2017 Jan. PLoS Negl Trop Dis. 2017. PMID: 28099433 Free PMC article.
-
The epidemiological dynamics of infectious trachoma may facilitate elimination.Epidemics. 2011 Jun;3(2):119-24. doi: 10.1016/j.epidem.2011.03.004. Epub 2011 Apr 6. Epidemics. 2011. PMID: 21624783 Free PMC article.
-
Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children.PLoS One. 2010 Jun 11;5(6):e11075. doi: 10.1371/journal.pone.0011075. PLoS One. 2010. PMID: 20552021 Free PMC article.
References
-
- Mabey DC, Solomon AW, Foster A. Trachoma. Lancet. 2003;362:223–229. - PubMed
-
- WHO. Planning meeting for the Global Elimination of Trachoma, Geneva, 25-28 November 1996. 1997. WHO/PBL/97.60 http://whqlibdoc.who.int/hq/1997/WHO_PBL_97.60.pdf.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous